期刊文献+

CD40和IL-6在冠状动脉粥样硬化性心脏病稳定性中的作用 被引量:4

Effects of CD40 and IL6 on the stability of coronary athrosclerotic heart disease
下载PDF
导出
摘要 【目的】从临床、造影和血清炎性介质方面综合评估冠状动脉粥样硬化斑块的稳定性。【方法】结合临床表现、心肌酶变化、冠脉造影结果,将2010年3月-2011年3月因胸痛胸闷住院的207例患者分为急性心肌梗死组(A组,30例)、不稳定心绞痛组(B组,90例)、稳定性心绞痛组(C组,36例)和正常对照组(D组,51例)。采用酶联免疫吸附法测定血清白细胞介素6(IL6)和分化抗原40(CD40)。【结果】A组肌红蛋白(MYO)较D组明显升高(183.5±17.1)ng/l vs(43.1±27.1)ng/l,肌钙蛋白(TNI)和肌酸激酶同工酶(CKMB)无明显升高。A组IL6和CD40较对照组明显升高,分别是(289.46±143.67)pg/ml vs(147.96±118.12)pg/ml和(8.67±7.29)ng/ml vs(5.37±1.57)ng/ml,具有统计学意义(P<0.05)。线性相关分析显示MYO和IL6、CD40无明显相关,IL6和CD40呈正相关(r=0.53,P=0.042)。【结论】急性心肌梗死组炎性介质水平升高,早期检验对预测斑块稳定性有一定意义。 【Objective】 To evaluate the stability of coronary athrosclerotic plaque by clinical manifestation,coronary angiography(CAG) and the levels of serum inflammatory markers.【Methods】 A total of 207 patients with chest pain were divided into 4 groups based on the clinical manifestation,ECG changes,myocardial markers and CAG: acute myocardial infarction(group A,n = 30),unstable angina(group B,n = 90),stable angina(group C,n = 36),normal(group D,n = 51).IL6 and CD40 serum level were measured in all the patients and the myocardial markers were recorded too.【Results】 There were no difference either in TNI or CKMB level,but the MYO level was significantly increased in group A than other groups.The serum level of IL6 in group A was higher only than normal group(289.46±143.67) pg/ml vs(147.96±118.12) pg/ml(P 〈 0.05),and the serum level of CD40 in group A was higher than group B,group C and group D respectively(8.67±7.29) ng/ml vs(5.37±1.57) ng/ml(P 〈 0.05).【Conclusion】 Serum level of IL6 and CD40 can be used as a good index for reflecting the stability of coronary artery disease.
出处 《武警医学院学报》 CAS 2012年第1期15-17,共3页 Acta Academiae Medicinae CPAPF
关键词 炎性介质 斑块稳定性 白细胞介素6 CD40 Inflammation marker Stability Coronary artery disease Serum level Myocardial marker
  • 相关文献

参考文献11

  • 1Koenig W,Khuseyinova N.Biomarkers of atheroscleroticplaque instability and rupture[J].Arterioscler Thromb VascBiol,2007,27:15.
  • 2Tousoulis D,Kampoli A,Stefanadi E,et al.New biomarkersin acute coronary syndrome[J].Curr Med Chem,2008,15:1288.
  • 3Rondina M,Lappe J,Carlquist J,et al.Soluble CD40 ligandas a predictor of coronary artery disease and long-termclinical outcomes in stable patients undergoing coronaryangiography[J].Cardiology,2008,6:436.
  • 4董军亚,张丽红,蔡伟,陈少伯,赵鹏,张梅,姜铁民.血清炎性介质与冠状动脉粥样硬化性心脏病稳定性的关系[J].武警医学院学报,2010,19(3):172-174. 被引量:1
  • 5Fouad HH,Al Dera H,Bakhoum SW,et al.Levels of sCD40ligand in chronic and acute coronary syndromes and itsrelation to angiographic extent of coronary arterial narrowing[J].Angiology,2010,21(6):567-573.
  • 6Munk PS,Breland UM,Aukrust P,et al.Inflammatory res-ponse to percutaneous coronary intervention in stable coron-ary artery disease[J].J Thromb Thromboly,2011,31(1):92-98.
  • 7Blagodatskikh KA,Evdokimova MA,Agapkina YV,et al.The polymorphisms G(-174)C in IL6 gene and G(-1082)A inIL10 gene are associated with poor outcomes in patients withacute coronary syndrome[J].Mol Biol,2010,44(5):741-747.
  • 8Wang Y,Li L,Tan H,et al.Transcoronary concentrationgradient of sCD40 and hsCRP in patients with coronary heartdisease[J].Clin Cardiol,2007,30:392.
  • 9Wenzel F,Baertl A,Zimmermann N,et al.Different beha-viour of soluble CD40L concentrations can be reflected byvariations of preanlytical conditions[J].Clin Hemo Micro-circ,2008,39:417.
  • 10Spagnoli L,Bonanno E,Sangiorgi G,et al.Role ofinflammation in atherosclerosis[J].J Nucl Med,2007,48:1800.

二级参考文献8

  • 1Hajek P,Macek M,Hladikova M,et al.Pregnancy-associated plasma protein A and proform eosinophilic major basic protein in the detection of different types of corollary artery disease[J].Physiol Res,2008,57:23-32.
  • 2Tousoulis D,Kampoli A,Stefanati E,et al.New biomarkers in acute coronary syndrome[J].Curt Med Chem,2008,15:1288-1296.
  • 3Arcar I,Zito F,Castelnuovoc A,et al.C reactive protein and its determinants in healthy men and women from Uropean regions at different risk of coronary disease:the IMMIDIET Project[J].J Thromb Haemost,2008,6:436-443.
  • 4Tobias P,Frank,Kathryn M,et al.Inflammation,the metabolic syndrome.and risk of coronary heart disease in women and men[J].Atherosclerosis,2008,197:392-399.
  • 5Li X,Zhou S,Tang J,et al.Association between plasma pregnancy-associated plasma protein A and restenosis after percutaneous coronary angioplasty[J].Cire J,2008,72:729-733.
  • 6Conover C,Harrlngton S,Bale K.Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells[J].Growth Hormone & IGF Research,2008,18:213-220.
  • 7Niccoli G,Biasucci L,Biscione C,et al.Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina[J].Atherosclerosis,2008,196:779-785.
  • 8Qin Q,Wittfooth S,Peterrson K.Measurement and clinical significance of circulating PAPP-A in ACS patients[J].Clini Chim Acta.2007.380:59-67.

同被引文献53

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部